RYTM
Rhythm Pharmaceuticals, Inc.$97.13-5.35 (-5.22%)Prev Close$102.44·MCap$7.18B·P/E—·Vol459.8K·Yield—
▲
Buys (12M)
0
$0.00
▼
Sells (12M)
19
$42.38M
◆
Net Activity
Net Seller
$42.38M
●
Active Insiders
9
last 12 mo
Over the past 12 months, insider activity at Rhythm Pharmaceuticals, Inc. (RYTM) has been exclusively selling, with 0 insider purchases totaling $0.00 and 19 insider sales totaling $42.38M. The most recent insider transaction was by Meeker David P (director, officer: President and CEO), who sold $5.13M worth of shares on Sep 14, 2026. Rhythm Pharmaceuticals, Inc. operates in the Healthcare sector, within the Biotechnology industry, with a market cap of $7.18B.
RYTM Insider Trading Activity
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Sep 14, 2026 | Meeker David P | director, officer: President and CEO | Sell | 50,000 | $102.67 | $5.13M | 282,819 |
| Sep 1, 2026 | Smith Hunter C | officer: Chief Financial Officer | Sell | 62,774 | $105.46 | $6.62M | 153,726-29% |
| Aug 17, 2026 | Shulman Joseph | officer: Chief Technical Officer | Sell | 5,079 | $119.75 | $608.2K | 15,915 |
| Aug 17, 2026 | Garfield Alastair | officer: Chief Scientific Officer | Sell | 7,763 | $117.57 | $912.7K | 8,051-49% |
| Aug 14, 2026 | Mazabraud Yann | officer: EVP, Head of International | Sell | 57,000 | $116.15 | $6.62M | 110,355-34% |
| Aug 14, 2026 | Lee Jennifer Kayden | officer: EVP, Head of North America | Sell | 75,834 | $117.38 | $8.90M | 0Exit |
| Jun 24, 2026 | TETRAULT LYNN A. | director | Sell | 37,000 | $100.32 | $3.71M | 7,000-84% |
| May 19, 2026 | German Christopher Paul | officer: Corporate Controller & CAO | Sell | 4,643 | $92.21 | $428.1K | 0Exit |
| Mar 6, 2026 | German Christopher Paul | officer: Corporate Controller & CAO | Sell | 5,614 | $89.56 | $502.8K | 160-97% |
| Feb 19, 2026 | Smith Hunter C | officer: Chief Financial Officer | Sell | 6,654 | $101.20 | $673.4K | 117,266 |
| Feb 17, 2026 | Smith Hunter C | Chief Financial Officer | Sell | 7,954 | $101.31 | $805.8K | 0 |
| Feb 12, 2026 | Smith Hunter C | officer: Chief Financial Officer | Sell | 7,071 | $100.21 | $708.6K | 123,624 |
| Feb 6, 2026 | Smith Hunter C | officer: Chief Financial Officer | Sell | 6,628 | $106.03 | $702.7K | 130,665 |
| Dec 15, 2025 | Cramer Pamela J. | Chief Human Resources Officer | Sell | 3,350 | $111.00 | $371.9K | 20,814 |
| Nov 24, 2025 | Cramer Pamela J. | Chief Human Resources Officer | Sell | 3,350 | $105.00 | $351.8K | 20,814 |
| Nov 12, 2025 | Cramer Pamela J. | Chief Human Resources Officer | Sell | 22,866 | $99.00 | $2.26M | 20,814-52% |
| Nov 3, 2025 | Shulman Joseph | Chief Technical Officer | Sell | 9,748 | $115.24 | $1.12M | 8,509-53% |
| Oct 30, 2025 | Shulman Joseph | Chief Technical Officer | Sell | 2,815 | $115.01 | $323.8K | 8,509 |
| Oct 20, 2025 | Shulman Joseph | Chief Technical Officer | Sell | 14,437 | $112.03 | $1.62M | 20,253-42% |
| Sep 4, 2025 | Shulman Joseph | Chief Technical Officer | Sell | 16,781 | $105.30 | $1.77M | 8,509-66% |
| Aug 25, 2025 | Shulman Joseph | Chief Technical Officer | Sell | 4,188 | $100.07 | $419.1K | 8,509-33% |
| Aug 14, 2025 | German Christopher Paul | Corporate Controller & CAO | Sell | 1,500 | $95.00 | $142.5K | 922-62% |
| Aug 14, 2025 | Smith Hunter C | Chief Financial Officer | Sell | 28,088 | $96.29 | $2.70M | 116,915 |
| Aug 13, 2025 | Shulman Joseph | Chief Technical Officer | Sell | 3,984 | $90.08 | $358.9K | 8,509-32% |
| Jul 29, 2025 | Cramer Pamela J. | Chief Human Resources Officer | Sell | 1,520 | $85.93 | $130.6K | 20,814 |
| Jul 11, 2025 | Cramer Pamela J. | Chief Human Resources Officer | Sell | 15,572 | $77.13 | $1.20M | 30,556-34% |
| Jul 11, 2025 | German Christopher Paul | Corporate Controller & CAO | Sell | 3,817 | $80.75 | $308.2K | 2,772-58% |
| Jul 11, 2025 | Shulman Joseph | Chief Technical Officer | Sell | 7,969 | $77.78 | $619.9K | 12,494-39% |
| Jul 11, 2025 | Smith Hunter C | Chief Financial Officer | Sell | 42,120 | $80.48 | $3.39M | 141,922 |
| Jul 3, 2025 | Garfield Alastair | Chief Scientific Officer | Sell | 1,319 | $64.81 | $85.5K | 3,132-30% |
| Jun 12, 2025 | German Christopher Paul | Corporate Controller & CAO | Sell | 2,069 | $67.19 | $139.0K | 1,889-52% |
| Jun 10, 2025 | Cramer Pamela J. | Chief Human Resources Officer | Sell | 7,031 | $68.05 | $478.4K | 19,209-27% |
| Jun 5, 2025 | MCGIRR DAVID W J | Director | Sell | 65,431 | $65.22 | $4.27M | 12,873-84% |
| Jun 5, 2025 | Meeker David P | President and CEO | Sell | 43,620 | $65.05 | $2.84M | 202,099 |
| Jun 3, 2025 | Smith Hunter C | Chief Financial Officer | Sell | 23,400 | $61.41 | $1.44M | 128,922 |
| May 1, 2025 | Cramer Pamela J. | Chief Human Resources Officer | Sell | 7,031 | $65.09 | $457.7K | 19,209-27% |
| May 1, 2025 | Mazabraud Yann | EVP, Head of International | Sell | 6,745 | $65.08 | $438.9K | 37,655 |
| Apr 10, 2025 | Cramer Pamela J. | Chief Human Resources Officer | Sell | 20,760 | $60.14 | $1.25M | 33,539-38% |
| Apr 10, 2025 | Mazabraud Yann | EVP, Head of International | Sell | 17,750 | $60.99 | $1.08M | 31,932-36% |
| Mar 24, 2025 | German Christopher Paul | Corporate Controller & CAO | Sell | 344 | $54.23 | $18.7K | 2,889 |
| Mar 18, 2025 | Mazabraud Yann | EVP, Head of International | Sell | 75,000 | $51.48 | $3.86M | 96,173-44% |
| Feb 19, 2025 | Cramer Pamela J. | Chief Human Resources Officer | Sell | 982 | $57.22 | $56.2K | 19,209 |
| Feb 19, 2025 | German Christopher Paul | Corporate Controller & CAO | Sell | 635 | $57.22 | $36.3K | 2,070 |
| Feb 19, 2025 | Lee Jennifer Kayden | EVP, Head of North America | Sell | 2,035 | $57.22 | $116.4K | 5,858-26% |
| Feb 19, 2025 | Meeker David P | President and CEO | Sell | 9,896 | $57.22 | $566.2K | 201,281 |
| Feb 19, 2025 | Shulman Joseph | Chief Technical Officer | Sell | 1,228 | $57.22 | $70.3K | 8,509 |
| Feb 19, 2025 | Smith Hunter C | Chief Financial Officer | Sell | 2,215 | $57.22 | $126.7K | 109,929 |
| Feb 14, 2025 | Lee Jennifer Kayden | EVP, Head of North America | Sell | 3,020 | $57.03 | $172.2K | 4,813-39% |
| Feb 14, 2025 | Shulman Joseph | Chief Technical Officer | Sell | 469 | $56.40 | $26.5K | 5,619 |
| Feb 14, 2025 | Smith Hunter C | Chief Financial Officer | Sell | 751 | $56.39 | $42.3K | 105,556 |
Showing 1–50 of 128
1 / 3
RYTM Insider Buying Activity
The following table shows recent insider purchases of Rhythm Pharmaceuticals, Inc. (RYTM) stock reported via SEC Form 4 filings.
No insider buying activity found for RYTM in the last 12 months.
RYTM Insider Selling Activity
The following table shows recent insider sales of Rhythm Pharmaceuticals, Inc. (RYTM) stock reported via SEC Form 4 filings.
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Sep 14, 2026 | Meeker David P | director, officer: President and CEO | Sell | 50,000 | $102.67 | $5.13M | 282,819 |
| Sep 1, 2026 | Smith Hunter C | officer: Chief Financial Officer | Sell | 62,774 | $105.46 | $6.62M | 153,726-29% |
| Aug 17, 2026 | Shulman Joseph | officer: Chief Technical Officer | Sell | 5,079 | $119.75 | $608.2K | 15,915 |
| Aug 17, 2026 | Garfield Alastair | officer: Chief Scientific Officer | Sell | 7,763 | $117.57 | $912.7K | 8,051-49% |
| Aug 14, 2026 | Mazabraud Yann | officer: EVP, Head of International | Sell | 57,000 | $116.15 | $6.62M | 110,355-34% |
| Aug 14, 2026 | Lee Jennifer Kayden | officer: EVP, Head of North America | Sell | 75,834 | $117.38 | $8.90M | 0Exit |
| Jun 24, 2026 | TETRAULT LYNN A. | director | Sell | 37,000 | $100.32 | $3.71M | 7,000-84% |
| May 19, 2026 | German Christopher Paul | officer: Corporate Controller & CAO | Sell | 4,643 | $92.21 | $428.1K | 0Exit |
| Mar 6, 2026 | German Christopher Paul | officer: Corporate Controller & CAO | Sell | 5,614 | $89.56 | $502.8K | 160-97% |
| Feb 19, 2026 | Smith Hunter C | officer: Chief Financial Officer | Sell | 6,654 | $101.20 | $673.4K | 117,266 |
| Feb 17, 2026 | Smith Hunter C | Chief Financial Officer | Sell | 7,954 | $101.31 | $805.8K | 0 |
| Feb 12, 2026 | Smith Hunter C | officer: Chief Financial Officer | Sell | 7,071 | $100.21 | $708.6K | 123,624 |
| Feb 6, 2026 | Smith Hunter C | officer: Chief Financial Officer | Sell | 6,628 | $106.03 | $702.7K | 130,665 |
| Dec 15, 2025 | Cramer Pamela J. | Chief Human Resources Officer | Sell | 3,350 | $111.00 | $371.9K | 20,814 |
| Nov 24, 2025 | Cramer Pamela J. | Chief Human Resources Officer | Sell | 3,350 | $105.00 | $351.8K | 20,814 |
| Nov 12, 2025 | Cramer Pamela J. | Chief Human Resources Officer | Sell | 22,866 | $99.00 | $2.26M | 20,814-52% |
| Nov 3, 2025 | Shulman Joseph | Chief Technical Officer | Sell | 9,748 | $115.24 | $1.12M | 8,509-53% |
| Oct 30, 2025 | Shulman Joseph | Chief Technical Officer | Sell | 2,815 | $115.01 | $323.8K | 8,509 |
| Oct 20, 2025 | Shulman Joseph | Chief Technical Officer | Sell | 14,437 | $112.03 | $1.62M | 20,253-42% |
| Sep 4, 2025 | Shulman Joseph | Chief Technical Officer | Sell | 16,781 | $105.30 | $1.77M | 8,509-66% |
| Aug 25, 2025 | Shulman Joseph | Chief Technical Officer | Sell | 4,188 | $100.07 | $419.1K | 8,509-33% |
| Aug 14, 2025 | German Christopher Paul | Corporate Controller & CAO | Sell | 1,500 | $95.00 | $142.5K | 922-62% |
| Aug 14, 2025 | Smith Hunter C | Chief Financial Officer | Sell | 28,088 | $96.29 | $2.70M | 116,915 |
| Aug 13, 2025 | Shulman Joseph | Chief Technical Officer | Sell | 3,984 | $90.08 | $358.9K | 8,509-32% |
| Jul 29, 2025 | Cramer Pamela J. | Chief Human Resources Officer | Sell | 1,520 | $85.93 | $130.6K | 20,814 |
| Jul 11, 2025 | Cramer Pamela J. | Chief Human Resources Officer | Sell | 15,572 | $77.13 | $1.20M | 30,556-34% |
| Jul 11, 2025 | German Christopher Paul | Corporate Controller & CAO | Sell | 3,817 | $80.75 | $308.2K | 2,772-58% |
| Jul 11, 2025 | Shulman Joseph | Chief Technical Officer | Sell | 7,969 | $77.78 | $619.9K | 12,494-39% |
| Jul 11, 2025 | Smith Hunter C | Chief Financial Officer | Sell | 42,120 | $80.48 | $3.39M | 141,922 |
| Jul 3, 2025 | Garfield Alastair | Chief Scientific Officer | Sell | 1,319 | $64.81 | $85.5K | 3,132-30% |
| Jun 12, 2025 | German Christopher Paul | Corporate Controller & CAO | Sell | 2,069 | $67.19 | $139.0K | 1,889-52% |
| Jun 10, 2025 | Cramer Pamela J. | Chief Human Resources Officer | Sell | 7,031 | $68.05 | $478.4K | 19,209-27% |
| Jun 5, 2025 | MCGIRR DAVID W J | Director | Sell | 65,431 | $65.22 | $4.27M | 12,873-84% |
| Jun 5, 2025 | Meeker David P | President and CEO | Sell | 43,620 | $65.05 | $2.84M | 202,099 |
| Jun 3, 2025 | Smith Hunter C | Chief Financial Officer | Sell | 23,400 | $61.41 | $1.44M | 128,922 |
| May 1, 2025 | Cramer Pamela J. | Chief Human Resources Officer | Sell | 7,031 | $65.09 | $457.7K | 19,209-27% |
| May 1, 2025 | Mazabraud Yann | EVP, Head of International | Sell | 6,745 | $65.08 | $438.9K | 37,655 |
| Apr 10, 2025 | Cramer Pamela J. | Chief Human Resources Officer | Sell | 20,760 | $60.14 | $1.25M | 33,539-38% |
| Apr 10, 2025 | Mazabraud Yann | EVP, Head of International | Sell | 17,750 | $60.99 | $1.08M | 31,932-36% |
| Mar 24, 2025 | German Christopher Paul | Corporate Controller & CAO | Sell | 344 | $54.23 | $18.7K | 2,889 |
| Mar 18, 2025 | Mazabraud Yann | EVP, Head of International | Sell | 75,000 | $51.48 | $3.86M | 96,173-44% |
| Feb 19, 2025 | Cramer Pamela J. | Chief Human Resources Officer | Sell | 982 | $57.22 | $56.2K | 19,209 |
| Feb 19, 2025 | German Christopher Paul | Corporate Controller & CAO | Sell | 635 | $57.22 | $36.3K | 2,070 |
| Feb 19, 2025 | Lee Jennifer Kayden | EVP, Head of North America | Sell | 2,035 | $57.22 | $116.4K | 5,858-26% |
| Feb 19, 2025 | Meeker David P | President and CEO | Sell | 9,896 | $57.22 | $566.2K | 201,281 |
| Feb 19, 2025 | Shulman Joseph | Chief Technical Officer | Sell | 1,228 | $57.22 | $70.3K | 8,509 |
| Feb 19, 2025 | Smith Hunter C | Chief Financial Officer | Sell | 2,215 | $57.22 | $126.7K | 109,929 |
| Feb 14, 2025 | Lee Jennifer Kayden | EVP, Head of North America | Sell | 3,020 | $57.03 | $172.2K | 4,813-39% |
| Feb 14, 2025 | Shulman Joseph | Chief Technical Officer | Sell | 469 | $56.40 | $26.5K | 5,619 |
| Feb 14, 2025 | Smith Hunter C | Chief Financial Officer | Sell | 751 | $56.39 | $42.3K | 105,556 |
RYTM Insiders
Similar Stocks to RYTM
VRTX
Vertex Pharmaceuticals Incorporated
$513.52-1.17%
$132.26B
REGN
Regeneron Pharmaceuticals, Inc.
$772.87-2.63%
$83.21B
MRNA
Moderna, Inc.
$142.93-2.49%
$57.13B
RVMD
Revolution Medicines, Inc.
$204.47-0.31%
$44.15B
INSM
Insmed Incorporated
$119.56-4.63%
$28.05B
INCY
Incyte Corporation
$121.65-0.43%
$24.62B
UTHR
United Therapeutics Corporation
$500.44-0.42%
$21.10B
NBIX
Neurocrine Biosciences, Inc.
$150.44-4.31%
$15.71B